Staar Surgical opened lower at $26.58, compared with its previous close of $26.69. In the last trading session, the stock traded between $26.10 and $27.21. It showed a sideways intraday trend.
An investment of $100 made 5 years ago in Staar Surgical is now worth
$ 23.69
Resulting in a loss of
$ 76.31 (76.31%)
Note: Past profits do not guarantee future returns.
Rating from 5 Analysts
Today's Change
+$0.10 (+0.39%)
Day High
$27.21
Day Low
$26.10
Day Open
$26.58
Prev Close
$26.69
Volume
6,12,326
1W Return
-1.46%
1M Return
21.55%
3M Return
7.43%
6M Return
-3.73%
1Y Return
-2.22%
Market Cap ($ Mn)
1,345
PE Ratio
276.38
PB Ratio
3.01
PEG Ratio
-
ROE
-22.57%
ROCE
-21.88%
EPS (TTM)
$0.11
1 Week
-1.46%
1 Month
21.55%
3 Months
7.43%
6 Months
-3.73%
9 Months
55.32%
STAAR Surgical authorizes $50 million share repurchase program
STAAR Surgical authorized a $50 million share repurchase program. Management cites confidence in business and undervaluation of shares. Company specializes in phakic IOLs including EVO ICL lenses.
8 days agoSTAAR Surgical to host Q3FY26 earnings call on November 4
STAAR Surgical releases Q3 2026 results on November 4, 2026. Earnings call scheduled for 5:30 pm ET on the same day. Webcast replay available for at least 90 days. Questions can be submitted in advance via email.
22 days agoLevi & Korsinsky launches probe into STAAR Surgical over fiduciary duties
Levi & Korsinsky investigates STAAR Surgical for possible fiduciary duty breaches. Shareholders can contact Joseph E. Levi via email or phone at no cost. The firm specializes in securities litigation and financial fraud cases. Investigation targets conduct of certain officers and directors.
22 days agoSTAAR Surgical appoints Andrew Pilon as vice president of business development
STAAR Surgical appointed Andrew Pilon, O.D., as Vice President of Business Development. Pilon joins from Johnson & Johnson Vision after nearly six years in senior business development roles. New hire will report to CEO Warren Foust and focus on strategic partnerships and portfolio expansion. Pilon previously held leadership roles at Bausch + Lomb and advised venture-backed ophthalmic companies.
1mo agoSTAAR Surgical board approves $50 million share repurchase program
STAAR Surgical authorized a $50 million share repurchase program. Buyback funded by existing cash reserves and free cash flow. Company reports zero outstanding debt as of July 3, 2026. Repurchase represents ~27.5% of total cash and investments.
1mo agoLevi & Korsinsky opens probe into STAAR Surgical over fiduciary breaches
Levi & Korsinsky initiated an investigation into STAAR Surgical (NASDAQ: STAA). The probe focuses on possible breaches of fiduciary duties by officers and directors. Shareholders can contact Joseph E. Levi at (212) 363-7500 for case details. The firm cites extensive experience in recovering funds for investors in securities fraud cases.
1mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 5 years ago in Staar Surgical is now worth
$ 23.69
Resulting in a loss of
$ 76.31 (76.31%)
Note: Past profits do not guarantee future returns.
